Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
BJU International|November 15, 2008
Therapeutic options in the management of intermediate-risk nonmuscle-invasive bladder cancerAndras Horvath, Hugh Mostafid
Current Opinion in Urology|December 7, 2017
Prevention of bladder cancer incidence and recurrence: nutrition and lifestyleChristian D Fankhauser, Hugh Mostafid
IEEE Journal of Translational Engineering in Health and Medicine|July 14, 2020
Rapid, Low-Cost Dielectrophoretic Diagnosis of Bladder Cancer in a Clinical SettingRashedul Hoque, Hugh Mostafid, Michael Pycraft Hughes
Current Opinion in Urology|August 24, 2018
What to do during Bacillus Calmette-Guérin shortage? Valid strategies based on evidenceMohammad Abufaraj, Hugh Mostafid, Shahrokh F Shariat, et al.
Current Opinion in Urology|March 7, 2020
Treatment options and results of adjuvant treatment in nonmuscle-invasive bladder cancer (NMIBC) during the Bacillus Calmette-Guérin shortageChristian Daniel Fankhauser, Jeremy Yuen-Chun Teoh, Hugh Mostafid
Nature Reviews. Urology|September 18, 2013
BCG immunotherapy for bladder cancer--the effects of substrain differencesChristine Gan, Hugh Mostafid, Muhammad Shamim Khan, et al.
International Journal of Pharmaceutics|September 5, 2017
Advances in intravesical drug delivery systems to treat bladder cancerOluwadamilola M Kolawole, Wing Man Lau, Hugh Mostafid, et al.
Archivos Espanoles De Urologia|May 11, 2018
BCG therapy in NMIBC: How much and for how long?Annelisse Ashton, Venkata Ramana Murthy Kusuma, Jeremy Crew, et al.
Pageof 7